- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Immunology Research
Volume 2014 (2014), Article ID 936270, 1 page
The Role of TH17-Associated Cytokines in Health and Disease
1Center for Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA
2Immunology Institute, Mount Sinai School of Medicine, Icahn Medical Institute, 1425 Madison Avenue, New York, NY 10029, USA
3Medical Department, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany
Received 14 April 2014; Accepted 14 April 2014; Published 29 April 2014
Copyright © 2014 William O’Connor Jr. et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The intriguing subset of effector CD4+ T cells termed TH17 cells are now widely appreciated for their role in coordinating immune and inflammatory responses. The dynamic nature of the TH17 cell subset allows for the adoption of inflammatory or regulatory functions as needed, in a microenvironment-dependent fashion. The ontogeny, tissue residence, migratory properties, and biological functions of these cells are areas of intense research focus given the broad spectrum of human disorders associated with aberrant TH17-type responses.
While TH17 cells are so named for their characteristic Interleukin 17 (IL-17) production, bona fide TH17 cells of human or murine origin produce, at times, a cacophony of inflammatory mediators, which can include IL-17, IL-21, IL-22, and IL-26. As such, dissecting the biological consequences of robust TH17 responses, properly or improperly controlled, has presented a number of challenges. Further confounding the study of TH17 cells and individual cytokines are the many observations documenting non- TH17 cell sources of these same cytokines. Given the complexity of TH17 biology, we welcome the reports found within this issue, highlighting current findings and observations and illuminating several components of TH17 cells and known associated cytokines.
N. Qu et al. provide an interesting overview of the roles TH17 cells and their associated cytokines play in various inflammatory diseases. N. Y. A. Hemdan et al. build on this premise, addressing the TH17 cell contributions to autoimmunity, in particular that which arises following exposure to xenobiotic substances.
In the absence of overt chronic inflammation, TH17 cells predominantly reside at mucosal surfaces. H.-C. Tsai et al. provide an elegant update on the functions of TH17 differentiation and on the functional consequences of IL-17 signaling in pulmonary inflammation. Y. Morishima et al. highlight the role of TH17-associated cytokines in asthma, especially in steroid-resistant disease. Further interesting findings from the Hizawa laboratory suggest an important role for IL-17F in particular.
TH17 cells, which are known to be induced in response to a variety of bacterial and fungal infections, may also be selectively depleted, as in the early stages of an HIV infection. S. L. Bixler and J. J. Mattapallil elegantly discuss potential mechanisms by which TH17 cells are depleted or improperly regulated during HIV infection.
Further, TH17 cells and TH17-produced cytokines have also been associated with tumor immunity and conversely with promoting the initiation/progression of tumorigenesis. In this issue, D. Alizadeh et al. discuss how TH17 cells and TH17-associated cytokines may act directly or indirectly toward shifting local microenvironments to favor tumor promotion or tumor suppression. Focusing on AML, T. Tian et al. examined TH17 cell frequencies in acute myeloid leukemia patients and discuss their observed stage-dependent variation.
It is our hope that you will find the articles within insightful; we have enjoyed reading all of these articles immensely.
William O’Connor Jr.